Clinical Trial Update: A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber [Phase 2]

View source ↗

Summary

A Phase 2 study comparing QAV680 to placebo for seasonal allergic rhinitis in an environmental exposure chamber, with the trial status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• QAV680

Snippet

Sponsor: Novartis | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED